Exciting news at Summa Biotech!
We are pleased to announce the appointment of Federica De Majo PhD as our Chief Scientific Officer.
After more than two years of working at Summa Biotech with outstanding contributions, leadership and innovative ideas she has proven to be more than capable of taking on this important role. With Federica guiding the science and bringing her molecular biology expertise, we’re ready to tackle the challenges ahead. Together, we will keep moving the mission of cardiac regeneration closer to reality.
July 2024: A new chapter begins at Summa Biotech!
We are thrilled to announce the opening of our new state-of-the-art lab!
This milestone marks a significant step forward in our mission to pioneer groundbreaking innovations in heart regeneration using RNA therapeutics. Our new lab will enhance our capabilities, accelerate our research, and bring us closer to achieving our bold vision.
We thank our friends and families who shared this thrilling moment with us and the Utrecht Science Park for hosting us with our lab!
♥️Let’s all make heart health a priority every day!
News
Behind the scenes, we have worked hard to lay a solid foundation, build our culture, and assemble the best team. This preparation ensures that upon launching this website, we are not just making an entrance; we are making a statement about who we are.
More news about Summa, our growing team and our brand new laboratory will follow soon. 